Rodent transgenesis mediated by a novel hyperactive Sleeping Beauty transposon system.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

DNA-based transposons are natural gene delivery vehicles. Similarly to retroviruses, these elements -integrate into the chromosomes of host cells, but their life-cycle does not involve reverse transcription and they are not infectious. Transposon-based gene delivery has several advantageous features compared to viral methods; however, its efficacy has been the bottleneck of transposon utilization. Recently, using a novel strategy for in vitro evolution, we created a new hyperactive version (SB100X) of the vertebrate-specific Sleeping Beauty (SB) transposase. SB100X, when coupled with enhanced inverted terminal repeat structure T2 type SB transposons, is over 100-fold more active in mammalian cells than the prototype. We established protocol for SB100X mediated rodent transgenesis resulting on the average 35% transgenic founders with a low average number (1-2) of transgene insertions per founder. Due to these characteristics the SB100X based protocol opens the possibility of designing SB based transgenes also for in vivo knockdown experiments. By the same token, single copy transgene units introduced by the SB transposon system, more than being less prone to transgene silencing, also allow better control of transgene expression levels and patterns.

Original languageEnglish
Pages (from-to)87-99
Number of pages13
JournalMethods in molecular biology (Clifton, N.J.)
Volume738
DOIs
Publication statusPublished - 2011

Fingerprint

Beauty
Gene Transfer Techniques
Transgenes
Rodentia
Transposases
DNA Transposable Elements
Terminal Repeat Sequences
Retroviridae
Life Cycle Stages
Genes
Reverse Transcription
Vertebrates
Chromosomes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{d53dc454733a4288bc3149558295d4e2,
title = "Rodent transgenesis mediated by a novel hyperactive Sleeping Beauty transposon system.",
abstract = "DNA-based transposons are natural gene delivery vehicles. Similarly to retroviruses, these elements -integrate into the chromosomes of host cells, but their life-cycle does not involve reverse transcription and they are not infectious. Transposon-based gene delivery has several advantageous features compared to viral methods; however, its efficacy has been the bottleneck of transposon utilization. Recently, using a novel strategy for in vitro evolution, we created a new hyperactive version (SB100X) of the vertebrate-specific Sleeping Beauty (SB) transposase. SB100X, when coupled with enhanced inverted terminal repeat structure T2 type SB transposons, is over 100-fold more active in mammalian cells than the prototype. We established protocol for SB100X mediated rodent transgenesis resulting on the average 35{\%} transgenic founders with a low average number (1-2) of transgene insertions per founder. Due to these characteristics the SB100X based protocol opens the possibility of designing SB based transgenes also for in vivo knockdown experiments. By the same token, single copy transgene units introduced by the SB transposon system, more than being less prone to transgene silencing, also allow better control of transgene expression levels and patterns.",
author = "L. M{\'a}t{\'e}s",
year = "2011",
doi = "10.1007/978-1-61779-099-7_6",
language = "English",
volume = "738",
pages = "87--99",
journal = "Methods in Molecular Biology",
issn = "1064-3745",
publisher = "Humana Press",

}

TY - JOUR

T1 - Rodent transgenesis mediated by a novel hyperactive Sleeping Beauty transposon system.

AU - Mátés, L.

PY - 2011

Y1 - 2011

N2 - DNA-based transposons are natural gene delivery vehicles. Similarly to retroviruses, these elements -integrate into the chromosomes of host cells, but their life-cycle does not involve reverse transcription and they are not infectious. Transposon-based gene delivery has several advantageous features compared to viral methods; however, its efficacy has been the bottleneck of transposon utilization. Recently, using a novel strategy for in vitro evolution, we created a new hyperactive version (SB100X) of the vertebrate-specific Sleeping Beauty (SB) transposase. SB100X, when coupled with enhanced inverted terminal repeat structure T2 type SB transposons, is over 100-fold more active in mammalian cells than the prototype. We established protocol for SB100X mediated rodent transgenesis resulting on the average 35% transgenic founders with a low average number (1-2) of transgene insertions per founder. Due to these characteristics the SB100X based protocol opens the possibility of designing SB based transgenes also for in vivo knockdown experiments. By the same token, single copy transgene units introduced by the SB transposon system, more than being less prone to transgene silencing, also allow better control of transgene expression levels and patterns.

AB - DNA-based transposons are natural gene delivery vehicles. Similarly to retroviruses, these elements -integrate into the chromosomes of host cells, but their life-cycle does not involve reverse transcription and they are not infectious. Transposon-based gene delivery has several advantageous features compared to viral methods; however, its efficacy has been the bottleneck of transposon utilization. Recently, using a novel strategy for in vitro evolution, we created a new hyperactive version (SB100X) of the vertebrate-specific Sleeping Beauty (SB) transposase. SB100X, when coupled with enhanced inverted terminal repeat structure T2 type SB transposons, is over 100-fold more active in mammalian cells than the prototype. We established protocol for SB100X mediated rodent transgenesis resulting on the average 35% transgenic founders with a low average number (1-2) of transgene insertions per founder. Due to these characteristics the SB100X based protocol opens the possibility of designing SB based transgenes also for in vivo knockdown experiments. By the same token, single copy transgene units introduced by the SB transposon system, more than being less prone to transgene silencing, also allow better control of transgene expression levels and patterns.

UR - http://www.scopus.com/inward/record.url?scp=79960926864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960926864&partnerID=8YFLogxK

U2 - 10.1007/978-1-61779-099-7_6

DO - 10.1007/978-1-61779-099-7_6

M3 - Article

VL - 738

SP - 87

EP - 99

JO - Methods in Molecular Biology

JF - Methods in Molecular Biology

SN - 1064-3745

ER -